KINTOR PHARMA-B: (1) RE-ELECTION OF RETIRING DIRECTORS; (2) RE-APPOINTMENT OF AUDITOR; (3) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (4) PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORA

香港交易所 · May 12, 2023 16:35

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

開拓藥業-B：(1) 重選退任董事； (2) 續聘核數師； (3) 發行股份及購回股份的一般授權； (4) 建議修訂現有組織章程大綱及細則以及採納新組織章程大綱及細則； (5) 建議增加法定股本； 及 (6) 股東週年大會通告

KINTOR PHARMA-B: (1) RE-ELECTION OF RETIRING DIRECTORS; (2) RE-APPOINTMENT OF AUDITOR; (3) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (4) PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORA

Risk Disclaimer

Statement

開拓藥業-B：(1) 重選退任董事； (2) 續聘核數師； (3) 發行股份及購回股份的一般授權； (4) 建議修訂現有組織章程大綱及細則以及採納新組織章程大綱及細則； (5) 建議增加法定股本；及 (6) 股東週年大會通告